Microglial phenotype: Is the commitment reversible?

Trends in Neurosciences

Volumn 29, Issue 2, 2006, Pages 68-74

  Schwartz, Michal ^a   Butovsky, Oleg ^a   Brück, Wolfgang ^b   Hanisch, Uwe Karsten ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GAMMA INTERFERON; INTERLEUKIN 4; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

BEHAVIOR; CELL ACTIVATION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DISEASE EXACERBATION; HUMAN; IMMUNITY; INFLAMMATION; MEDICAL RESEARCH; MICROGLIA; NERVE CELL LESION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STIMULUS;

EID: 32044442102     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2005.12.005     Document Type: Article

References (77)

1. M.L. Block, and J.S. Hong Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism Prog. Neurobiol. 76 2005 77 98
2. R. Ladeby Microglial cell population dynamics in the injured adult central nervous system Brain Res. Rev. 48 2005 196 206
3. L. Minghetti Role of inflammation in neurodegenerative diseases Curr. Opin. Neurol. 18 2005 315 321
4. E. Sapp Early and progressive accumulation of reactive microglia in the Huntington disease brain J. Neuropathol. Exp. Neurol. 60 2001 161 172
5. S.A. Sargsyan Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis Glia 51 2005 241 253
6. W.J. Streit Microglia and Alzheimer's disease pathogenesis J. Neurosci. Res. 77 2004 1 8
7. T. Wang MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration FASEB J. 19 2005 1134 1136
8. P. Weydt Increased cytotoxic potential of microglia from ALS-transgenic mice Glia 48 2004 179 182
9. O. Butovsky Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective Mol. Cell. Neurosci. 29 2005 381 393
10. U.K. Hanisch Microglia as a source and target of cytokines Glia 40 2002 140 155
11. W.J. Streit Microglia as neuroprotective, immunocompetent cells of the CNS Glia 40 2002 133 139
12. W.J. Streit Microglia and neuroprotection: implications for Alzheimer's disease Brain Res. Rev. 48 2005 234 239
13. O. Butovsky Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7-2 (CD86) and prevention of cyst formation FASEB J. 15 2001 1065 1067
14. I. Shaked Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system J. Neuroimmunol. 146 2004 84 93
15. I. Shaked Protective autoimmunity: interferon-γ enables microglia to remove glutamate without evoking inflammatory mediators J. Neurochem. 92 2005 997 1009
16. W.J. Streit Dystrophic microglia in the aging human brain Glia 45 2004 208 212
17. L. Ma Microglia density decreases with age in a mouse model of Huntington's disease Glia 43 2003 274 280
18. M.J. Carson Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis Glia 40 2002 218 231
19. D. van Rossum, and U.K. Hanisch Microglia Metab. Brain Dis. 19 2004 393 411
20. M. Schwartz Protective autoimmunity against the enemy within: fighting glutamate toxicity Trends Neurosci. 26 2003 297 302
21. M. Lotan, and M. Schwartz Cross talk between the immune system and the nervous system in response to injury: implications for regeneration FASEB J. 8 1994 1026 1033
22. S.L. Carlson Acute inflammatory response in spinal cord following impact injury Exp. Neurol. 151 1998 77 88
23. S. Constantini, and W. Young The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats J. Neurosurg. 80 1994 97 111
24. I. Dusart, and M.E. Schwab Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord Eur. J. Neurosci. 6 1994 712 724
25. M.T. Fitch Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma J. Neurosci. 19 1999 8182 8198
26. R.S. Ghirnikar Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat J. Neurosci. Res. 64 2001 582 589
27. A.E. Mautes Vascular events after spinal cord injury: contribution to secondary pathogenesis Phys. Ther. 80 2000 673 687
28. P.G. Popovich Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury Exp. Neurol. 158 1999 351 365
29. E. Hauben Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease J. Clin. Invest. 108 2001 591 599
30. J. Kipnis Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration J. Neurosci. 24 2004 6133 6143
31. G. Moalem Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy Nat. Med. 5 1999 49 55
32. S. Muhallab Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis Scand. J. Immunol. 55 2002 264 273
33. O. Rapalino Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats Nat. Med. 4 1998 814 821
34. H. Hammarberg Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells J. Neurosci. 20 2000 5283 5291
35. J. Kipnis T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies Proc. Natl. Acad. Sci. U. S. A. 97 2000 7446 7451
36. S. David Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system Neuron 5 1990 463 469
37. S.S. Ousman, and S. David MIP-1α, MCP-1, GM-CSF, and TNF-α control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord J. Neurosci. 21 2001 4649 4656
38. E. Hauben Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion J. Neurosci. 20 2000 6421 6430
39. E. Hauben Autoimmune T cells as potential neuroprotective therapy for spinal cord injury Lancet 355 2000 286 287
40. s) that causes delayed Wallerian degeneration J. Comp. Neurol. 371 1996 485 495
41. A. Yagihashi Macrophage colony stimulating factor (M-CSF) protects spiral ganglion neurons following auditory nerve injury: morphological and functional evidence Exp. Neurol. 192 2005 167 177
42. S.C. Byram CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation J. Neurosci. 24 2004 4333 4339
43. Z. Zhang Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response Exp. Neurol. 143 1997 141 152
44. J.R. Bethea Systemically administered interleukin-10 reduces tumor necrosis factor-α production and significantly improves functional recovery following traumatic spinal cord injury in rats J. Neurotrauma 16 1999 851 863
45. G.M. Kim Tumor necrosis factor receptor deletion reduces nuclear factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury J. Neurosci. 21 2001 6617 6625
46. J.L. Mason Interleukin-1β promotes repair of the CNS J. Neurosci. 21 2001 7046 7052
47. W.J. Streit Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukinn-6 in neuron-glia signaling during regeneration J. Neurosci. Res. 61 2000 10 20
48. M. Schwartz, and E. Hauben Differing views on spinal cord repair Science 296 2002 1400
49. J. Fisher Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility J. Neuroimmunol. 119 2001 1 9
50. J. Kipnis Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response J. Neurosci. 21 2001 4564 4571
51. H. Schori Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma Proc. Natl. Acad. Sci. U. S. A. 98 2001 3398 3403
52. H. Schori T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system J. Neuroimmunol. 119 2001 199 204
53. E. Yoles Protective autoimmunity is a physiological response to CNS trauma J. Neurosci. 21 2001 3740 3748
54. H. Avidan Vaccination with autoantigen protects against aggregated β-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells Eur. J. Immunol. 34 2004 3434 3445
55. S. Bakalash Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma Invest. Ophthalmol. Vis. Sci. 44 2003 3374 3381
56. J. Fisher Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies J. Neurosci. 21 2001 136 142
57. E. Hauben Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens Proc. Natl. Acad. Sci. U. S. A. 98 2001 15173 15178
58. Kipnis, J. et al. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. (in press)
59. T. Mizrahi The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis J. Immunol. 169 2002 5971 5977
60. T. Olsson Genetic dissection of neurodegeneration and CNS inflammation J. Neurol. Sci. 233 2005 99 108
61. K.G. Häusler Interferon-γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages Eur. J. Neurosci. 16 2002 2113 2122
62. J. Hsieh IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes J. Cell Biol. 164 2004 111 122
63. M.A. Aberg IGF-I has a direct proliferative effect in adult hippocampal progenitor cells Mol. Cell. Neurosci. 24 2003 23 40
64. J.R. O'Kusky Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development J. Neurosci. 20 2000 8435 8442
65. M.A. Aberg Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus J. Neurosci. 20 2000 2896 2903
66. M.J. Carson Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice Neuron 10 1993 729 740
67. W.H. Shen Tumor necrosis factor α inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation Endocrinology 145 2004 3101 3105
68. R.J. Lichtenwalner Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis Neuroscience 107 2001 603 613
69. Butovsky, O. et al. Microglia activated by IL-4- or IFN-γ differently induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. (in press)
70. L. Bernardino Modulator effects of interleukin-1β and tumor necrosis factor-α on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures J. Neurosci. 25 2005 6734 6744
71. Y. Kitamura Recovery of focal brain ischemia-induced behavioral dysfunction by intracerebroventricular injection of microglia J. Pharmacol. Sci. 97 2005 289 293
72. J.S. Duffield The inflammatory macrophage: a story of Jekyll and Hyde Clin. Sci. (Lond.) 104 2003 27 38
73. S. Gordon Alternative activation of macrophages Nat. Rev. Immunol. 3 2003 23 35
74. J. Ma Regulation of macrophage activation Cell. Mol. Life Sci. 60 2003 2334 2346
75. D.M. Mosser The many faces of macrophage activation J. Leukoc. Biol. 73 2003 209 212
76. M. Stein Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation J. Exp. Med. 176 1992 287 292
77. U.K. Hanisch The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls Eur. J. Immunol. 31 2001 2104 2115